COVID-19 is a rapidly evolving global pandemic that has effected more than 2 million people worldwide so far. Recent studies indicate that the invasion of the respiratory tract occurs through the angiotensin converting enzyme 2 receptor. Interestingly, these receptors are highly expressed by the heart, and are involved in cardiac function mediated by the renin-angiotensin system as well as in the development of systemic hypertension and diabetes mellitus. Clinical manifestations of COVID-19 are dominated by respiratory symptoms including fever, cough, and shortness of breath, with potential development into severe pneumonia. In a group of patients, the disease can cause severe cardiovascular complications such as acute myocardial injury, myocarditis, arrhythmias, and venous thromboembolism. In addition, patients with pre-existing cardiovascular disease, diabetes mellitus, and congestive heart failure might have an increased risk of death. Therefore, understanding the mechanisms involved in cardiovascular injury caused by SARS-CoV-2 is paramount for the development of effective treatments in patients with cardiac disease.
• Special issue articles can include both original unpublished research articles and review articles related to the specific theme.
• Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.
• All the articles in special issues should strictly adhere to journal style and formatting.
• All accepted manuscripts can be submitted online via https://www.pulsus.com/submissions/clinical-cardiology-journal.html or through an email id to [email protected]m Submission should be accompanied by a cover letter with reference to the concerned special issue theme.
For further information on special issue guidelines and submission process, please contact [email protected]
Please visit Instruction for author’s page to know more about article formatting and guidelines: https://www.pulsus.com/clinical-cardiology-journal/instructions-to-authors.html